Hematology NewsGerman CLLM1 study: 4-year data raise concerns about lenalidomide maintenanceSeptember 27, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsICLL-07 trial: MRD-driven strategy yields prolonged survivalSeptember 27, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsGALACTIC CLL trial: Obinutuzumab consolidation helps eradicate MRDSeptember 26, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsCK doesn’t seem to affect OS in CLL patients taking idelalisibSeptember 5, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsCalquence earns breakthrough designation for CLL monotherapyAugust 27, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsZanubrutinib may be poised to challenge ibrutinib for CLLAugust 15, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsICYMI: Ibrutinib/rituximab combo improves CLL survivalJuly 31, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsBTK mutations linked to CLL progression on ibrutinibJuly 24, 2019CLLLymphoma & Plasma Cell DisordersB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA approves rituximab biosimilar for cancer, autoimmune disordersJuly 23, 2019B Cell LymphomaCLLLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsIbrutinib-venetoclax found highly active in hard-to-treat CLLJuly 22, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Potential improvements in convenience, tolerability of hematologic treatmentJuly 19, 2019Patient & Survivor CareMultiple MyelomaCLL
Hematology NewsAcalabrutinib extends PFS in advanced CLLJuly 11, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsIbrutinib tops chlorambucil against CLLJuly 10, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaRare Diseases
Hematology NewsHedgehog signaling offers prognostic, therapeutic potential in CLLJune 25, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsFixed-duration venetoclax-obinutuzumab superior to standard CLL therapyJune 7, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
